These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 4149775

  • 1. Anticancer activity of zoanthids and the associated toxin, palytoxin, against Ehrlich ascites tumor and P-388 lymphocytic leukemia in mice.
    Quinn RJ, Kashiwagi M, Moore RE, Norton TR.
    J Pharm Sci; 1974 Feb; 63(2):257-60. PubMed ID: 4149775
    [No Abstract] [Full Text] [Related]

  • 2. Isolate from the annelid, Reteterebella queenslandia (Australia), active against Ehrlich ascites tumor.
    Norton TR, Kashiwagi M, Quinn RJ.
    J Pharm Sci; 1973 Sep; 62(9):1464-8. PubMed ID: 4743093
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vivo antitumor activity and other pharmacological properties of halitoxin obtained from the sponge Haliclona viridis.
    Baslow MH, Turlapaty P.
    Proc West Pharmacol Soc; 1969 Sep; 12():6-8. PubMed ID: 5812303
    [No Abstract] [Full Text] [Related]

  • 6. Intraperitoneal chemotherapy with melphalan plus glutaminase.
    Holcenberg J, Anderson T, Ritch P, Skibba J, Howser D, Ring B, Adams S, Helmsworth M.
    Cancer Res; 1983 Mar; 43(3):1381-8. PubMed ID: 6825107
    [No Abstract] [Full Text] [Related]

  • 7. Antitumor activity in mice of tentacles of 2 tropical sea annelids.
    Tabrah FL, Kashiwagi M, Norton TR.
    Science; 1970 Oct 09; 170(3954):181-3. PubMed ID: 5456611
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Differenciation of reaction mechanisms of alkylating cytostatics on Ehrlich ascites-carcinoma- and lymphatic leucemic cells].
    Kummer D, Ochs HD.
    Z Krebsforsch; 1970 Mar 10; 73(4):315-28. PubMed ID: 4245611
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Comparative studies of the cytostatic effect of a new N-Lost derivative "IMET 3393" and Endoxan in 3 experimental mice tumors (Ehrlich ascites carcinoma, sarcoma 180 solid, leukemia LAJ I)].
    Schnabel R, Jungstand W, Gutsche W, Grimm H, Fritsch S.
    Acta Biol Med Ger; 1967 Mar 10; 19(4):543-58. PubMed ID: 5596676
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibiting effect of dehydroascorbic acid on cell division in ascites tumors in mice.
    Poydock ME, Reikert D, Rice J, Aleandri L.
    Exp Cell Biol; 1982 Mar 10; 50(1):34-8. PubMed ID: 7060819
    [Abstract] [Full Text] [Related]

  • 19. Lack of correlation between antitumour response and serum interferon levels in mice treated with SSM, an immunotherapeutic anticancer agent.
    Suzuki F, Brutkiewicz RR, Pollard RB.
    Br J Cancer; 1986 Apr 10; 53(4):567-70. PubMed ID: 3085702
    [No Abstract] [Full Text] [Related]

  • 20. Antileukemia activity in the Osillatoriaceae: isolation of Debromoaplysiatoxin from Lyngbya.
    Mynderse JS, Moore RE, Kashiwagi M, Norton TR.
    Science; 1977 Apr 29; 196(4289):538-40. PubMed ID: 403608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.